Ledbetter Eric C, Munger Robert J, Ring Rachel D, Scarlett Janet M
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401,USA.
Vet Ophthalmol. 2006 Mar-Apr;9(2):77-87. doi: 10.1111/j.1463-5224.2006.00439.x.
To determine the efficacy of two antimicrobial-chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects (SCCED) and ulcerative keratitis associated with bullous keratopathy in dogs.
Eighty dogs with SCCED and 14 dogs with ulcerative keratitis associated with bullous keratopathy.
Following manual debridement of nonadherent epithelium, dogs were treated topically with a chondroitin sulfate ophthalmic solution containing either tobramycin or ciprofloxacin. Patients were re-evaluated at 2-week intervals for 4 weeks.
After 2 weeks of treatment, 53.6% of eyes with SCCED and 17.6% of eyes with ulcerative keratitis associated with bullous keratopathy had healed. After 4 weeks of treatment, 81.0% of eyes with SCCED and 23.5% of eyes with ulcerative keratitis associated with bullous keratopathy had healed. There were no statistically significant differences in healing percentages between the tobramycin-chondroitin sulfate solution treatment groups and the ciprofloxacin-chondroitin sulfate solution treatment groups. Two dogs with SCCED, one treated with the tobramycin-chondroitin sulfate solution and the other treated with the ciprofloxacin-chondroitin sulfate solution, developed sterile corneal stromal abscesses during the study.
Topical therapy with an antimicrobial-chondroitin sulfate ophthalmic solution combined with manual debridement of nonadherent epithelium compares favorably with other published medical and surgical therapies for SCCED; however, these compounds are only equivocally more effective than therapy with manual debridement alone. These solutions appear to be ineffective in the treatment of ulcerative keratitis associated with bullous keratopathy. The significance of the two cases of corneal stromal abscessation is unknown at this time and warrants further investigation.
确定两种抗菌硫酸软骨素眼药水对犬自发性慢性角膜上皮缺损(SCCED)以及与大泡性角膜病变相关的溃疡性角膜炎的治疗效果。
80只患有SCCED的犬以及14只患有与大泡性角膜病变相关的溃疡性角膜炎的犬。
在手动清除非粘连上皮后,给犬局部使用含妥布霉素或环丙沙星的硫酸软骨素眼药水。每隔2周对患者进行重新评估,持续4周。
治疗2周后,53.6%患有SCCED的眼睛以及17.6%患有与大泡性角膜病变相关的溃疡性角膜炎的眼睛已愈合。治疗4周后,81.0%患有SCCED的眼睛以及23.5%患有与大泡性角膜病变相关的溃疡性角膜炎的眼睛已愈合。妥布霉素硫酸软骨素溶液治疗组和环丙沙星硫酸软骨素溶液治疗组之间的愈合百分比无统计学显著差异。两只患有SCCED的犬,一只用妥布霉素硫酸软骨素溶液治疗,另一只用环丙沙星硫酸软骨素溶液治疗,在研究期间出现了无菌性角膜基质脓肿。
抗菌硫酸软骨素眼药水局部治疗联合手动清除非粘连上皮,与其他已发表的针对SCCED的药物和手术治疗相比具有优势;然而,这些药物仅比单纯手动清除更有效,但效果不明确。这些溶液似乎对与大泡性角膜病变相关的溃疡性角膜炎治疗无效。这两例角膜基质脓肿的意义目前尚不清楚,值得进一步研究。